Autoimmune Life Blog

My son Peter was diagnosed with type 1 diabetes in 2013, just a few days before his third birthday. The years since have been a trial-by-fire learning experience.

BRI’s Matt Dufort, PhD, and Peter Linsley, PhD, led two new studies that could help doctors predict how quickly type 1 diabetes (T1D) will progress in some people, and match them with treatments that could slow it down. Dr.

In the late 1970s, Virginia Mason researchers had a groundbreaking idea: Use a portable pump to deliver insulin in patients with type 1 diabetes (T1D).

Treatment options for inflammatory bowel disease (IBD) have been limited for most of Elisa Boden, MD’s career. Until a few years ago, she and her colleagues – including James Lord, MD, PhD, and Michael Chiorean, MD – have had only a few types of medications to treat IBD.

"My son Peter is one of eight students at his elementary school with type 1 diabetes. Ranging in age from 5 to 10, the diabetes kids are part of a small but mighty community built on care, comfort and normalcy."

Some people go the extra mile for their favorite cause.

Dr. Gerald (Jerry) Nepom, who founded BRI’s Diabetes Research Program in the 1980’s, and who led BRI’s growth as a world-class research institute for 3 decades, now devotes his time to a laser-focused effort on getting experimental therapies to patients.

BRI has made game-changing discoveries and significantly expanded our research and funding in recent years.

When type 1 diabetes (T1D) strikes, it impacts the whole family in every way imaginable, day and night, forever. For siblings, the changes that come when a sister or brother is diagnosed with T1D hit like an earthquake, sudden and seismic.

Winter is coming, brace yourself. While for many this means singing carols and enjoying the holiday lights, for those living with autoimmune diseases including type 1 diabetes, rheumatoid arthritis, multiple sclerosis, and lupus, it can mean a flurry of concerns.